MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

EVGN — EVOGENE LTD.

Nasdaq

EVOGENE LTD.

CompareBack to Screener
$0.43
-0.01(-2.43%)
O
0.41
H
0.45
L
0.41
V
137.56K
⏱️ End-of-day dataAs of Oct 2, 2026

Chart

About EVGN

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

IndustryCommon Stock
SectorNot available
IPO DateMar 5, 2008
Employees52
Stock ExchangeNasdaq
Ticker SymbolEVGN

Key Financial Statistics

Market Cap$6.72M
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$0.35 - $1.50
52-Week Avg Volume921.7K
VWAP$0.42
Transactions743
Total Recorded Bars4,015 days